Results 191 to 200 of about 4,378 (208)

Larotrectinib Monotherapy After a Subtotal Resection of Infantile Hemispheric Glioma With TPM3::NTRK1 Fusion

Pediatric Blood & Cancer
S. Yokoyama, Utako Oba, Toya Shunichiro, Yoshinao Oda, Koji Yoshimoto, Yasunari Sakai, Yuhki Koga, Shouichi Ohga   +7 more
semanticscholar   +1 more source

Unraveling the molecular interaction of Larotrectinib with calf thymus DNA: A comprehensive study using multi-spectroscopic, thermodynamic, and computational techniques.

Biophysical Chemistry
Manal A. Alossaimi, Taibah Aldakhil, H. Elmansi, Fathalla Belal, Galal Magdy   +4 more
semanticscholar   +1 more source

Long-term Efficacy and Safety of Larotrectinib in Pediatric Patients with Primary CNS and Non-Primary CNS TRK Fusion Tumors

OncoDaily Medical Journal
Omar Chamdine, L. Mascarenhas, F. Doz, B. Geoerger, Steven G. DuBois, S. Perreault, C. Michel Zwaan, Catherine M. Albert, Claudia Blattman, Anna Nilsson, R. Kebudi, K. Nysom, V. Bernard-Gauthier, E. De La Cuesta, Natascha Neu, Theodore W. Laetsch, Yizhuo Zhang, Cornelis M. van Tilburg   +17 more
semanticscholar   +1 more source

Entrectinib/larotrectinib/selitrectinib

Reactions Weekly, 2019
openaire   +1 more source

EE646 Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib

Value in Health
Jongho Park, YiSook Jung, Hankil Lee
semanticscholar   +1 more source

969P Real-world study of larotrectinib in patients with TRK fusion solid tumours: Interim analysis of ON-TRK

Annals of Oncology
J.C. Trent, H. Wang, T. Watt, W. Choi, F.H. Schilling, J. Glade Bender, B. Kasenda, G. Tabatabai, D. Burcoveanu, N. Neu, C.P. Carrasco, D. Hong, T. Laetsch   +12 more
semanticscholar   +1 more source

Larotrectinib/Selitrectinib

Reactions Weekly
openaire   +1 more source

Variable redifferentiation effect of larotrectinib for NTRK fusion-positive pediatric papillary thyroid carcinoma and disease outcomes off therapy

Endocrine Abstracts
Luz E Castellanos, Sireesha Yedururi, Steven G Waguespack   +2 more
semanticscholar   +1 more source

970P Efficacy and safety of larotrectinib in patients with TRK fusion cancer who achieved complete response

Annals of Oncology
N. Federman, A. Drilon, H. Toledano, C. M. Albert, F. Doz, R. Xu, B. Geoerger, L. Mascarenhas, C. Qi, M. Dierselhuis, D. Burcoveanu, N. Brega, N. Neu, C. van Tilburg, T. Laetsch, D. Hong   +15 more
semanticscholar   +1 more source

Orphan designation: Larotrectinib, Treatment of glioma

Case Medical Research, 2019
openaire   +2 more sources